Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
43.40
Dollar change
+0.25
Percentage change
0.58
%
Index- P/E9.96 EPS (ttm)4.36 Insider Own1.64% Shs Outstand148.15M Perf Week4.30%
Market Cap6.43B Forward P/E9.41 EPS next Y4.61 Insider Trans-0.51% Shs Float145.73M Perf Month13.97%
Income644.00M PEG2.06 EPS next Q0.96 Inst Own79.65% Short Float8.04% Perf Quarter-2.49%
Sales4.63B P/S1.39 EPS this Y-2.87% Inst Trans2.23% Short Ratio3.57 Perf Half Y30.84%
Book/sh34.46 P/B1.26 EPS next Y9.20% ROA0.76% Short Interest11.72M Perf Year44.91%
Cash/sh- P/C- EPS next 5Y4.83% ROE12.95% 52W Range18.26 - 46.15 Perf YTD-1.07%
Dividend Est.1.67 (3.84%) P/FCF8.14 EPS past 5Y1.26% ROI10.25% 52W High-5.96% Beta1.13
Dividend TTM1.64 (3.78%) Quick Ratio- Sales past 5Y9.97% Gross Margin- 52W Low137.68% ATR (14)1.31
Dividend Ex-DateFeb 14, 2024 Current Ratio0.26 EPS Y/Y TTM-24.81% Oper. Margin17.59% RSI (14)63.90 Volatility2.42% 3.30%
Employees9679 Debt/Eq0.86 Sales Y/Y TTM39.40% Profit Margin13.92% Recom3.00 Target Price45.40
Option/ShortYes / Yes LT Debt/Eq0.13 EPS Q/Q-57.69% Payout37.74% Rel Volume0.60 Prev Close43.15
Sales Surprise-3.06% EPS Surprise-11.39% Sales Q/Q20.67% EarningsJan 22 BMO Avg Volume3.28M Price43.40
SMA206.50% SMA506.35% SMA20018.34% Trades Volume1,958,721 Change0.58%
Date Action Analyst Rating Change Price Target Change
Jan-05-24Downgrade Truist Buy → Hold $51 → $46
Dec-15-23Downgrade Robert W. Baird Outperform → Neutral $45
Nov-21-23Downgrade Citigroup Buy → Neutral $37
Oct-06-23Resumed Piper Sandler Neutral $34
Sep-29-23Initiated Citigroup Buy $42
Sep-27-23Downgrade Morgan Stanley Equal-Weight → Underweight $27 → $32
Jul-24-23Downgrade JP Morgan Overweight → Neutral $39
Jul-11-23Downgrade Jefferies Buy → Hold $37 → $30
Jun-15-23Downgrade Janney Buy → Neutral $35
May-22-23Initiated Hovde Group Outperform $40
Mar-26-24 05:50PM
Mar-18-24 10:33AM
09:40AM
Mar-15-24 01:30PM
Mar-08-24 11:00AM
06:32AM Loading…
Mar-07-24 06:32AM
Mar-04-24 09:54AM
09:12AM
08:53AM
Mar-01-24 06:47PM
06:34PM
03:46PM
10:34AM
09:40AM
Feb-28-24 11:24PM
09:31AM Loading…
09:31AM
Feb-23-24 04:59PM
04:36PM
04:16PM
Feb-22-24 08:00AM
Feb-14-24 09:40AM
Feb-08-24 03:11PM
03:08AM
Feb-07-24 06:52PM
09:52AM
Feb-02-24 03:19PM
10:52AM
08:00AM
08:00AM
Jan-29-24 07:01PM
08:15AM Loading…
Jan-25-24 08:15AM
Jan-24-24 08:00AM
06:04AM
Jan-23-24 11:12AM
07:38AM
07:19AM
Jan-22-24 09:55PM
05:03PM
04:47PM
04:34PM
04:10PM
03:48PM
12:36PM
Jan-19-24 04:19PM
Jan-15-24 11:12AM
Jan-09-24 12:23PM
Jan-03-24 01:28PM
Dec-15-23 05:00AM
Dec-14-23 12:50PM
Dec-13-23 05:12PM
Nov-30-23 12:31PM
Nov-27-23 06:48PM
Nov-20-23 03:37PM
Nov-17-23 03:00PM
Nov-16-23 12:52AM
Nov-14-23 05:14PM
Oct-29-23 07:43AM
Oct-27-23 01:21PM
Oct-25-23 05:19PM
Oct-19-23 07:36PM
04:55PM
04:13PM
12:22PM
12:10PM
08:35AM
08:10AM
Oct-18-23 06:37PM
05:55PM
05:46PM
05:42PM
05:19PM
04:49PM
04:10PM
Oct-17-23 07:42PM
10:00AM
Oct-13-23 12:27PM
Oct-04-23 06:56AM
Oct-03-23 07:45PM
04:18PM
Oct-01-23 10:00AM
Sep-29-23 05:48PM
04:59PM
04:51PM
12:17PM
Sep-27-23 10:52AM
10:00AM
08:58AM
02:37AM
Sep-22-23 07:07AM
Sep-15-23 10:49AM
Sep-14-23 12:23PM
12:00PM
Sep-12-23 05:10PM
12:17PM
Sep-06-23 12:06PM
Aug-30-23 12:01PM
06:00AM
Aug-22-23 04:14PM
Aug-15-23 06:14PM
03:43PM
Zions Bancorporation NA is a bank holding company, which engages in the provision of full banking and related services. It operates through the following segments: Zions Bank, Amegy Bank, California Bank & Trust, National Bank of Arizona, Nevada State Bank, Vectra Bank Colorado, and The Commerce Bank of Washington. The company was founded on February 17, 1961, and is headquartered in Salt Lake City, UT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SIMMONS HARRIS HChairman & CEOFeb 27 '24Buy38.544,000154,1601,312,987Feb 28 05:18 PM
Young Mark RichardExec VPFeb 22 '24Sale40.215,597225,05512,133Feb 26 04:49 PM
STEPHENS STEVEN DANExecutive Vice PresidentFeb 16 '24Sale40.817,500306,07544,056Feb 20 06:25 PM
SIMMONS HARRIS HChairman & CEOFeb 06 '24Buy38.993,600140,3501,261,866Feb 07 05:16 PM
ANDERSON A SCOTTExec VP andFeb 06 '24Sale39.2483232,6490Feb 07 05:16 PM
ANDERSON A SCOTTExec VP andJan 26 '24Sale44.254,093181,11514,665Jan 29 04:49 PM
MCLEAN SCOTT JPresidentDec 19 '23Sale38.3251919,888112,710Dec 20 04:34 PM
STEPHENS STEVEN DANExecutive Vice PresidentDec 19 '23Sale38.322609,96343,895Dec 20 04:34 PM
ANDERSON A SCOTTExec VP andDec 19 '23Sale38.322569,81018,758Dec 20 04:35 PM
Maio Keith DEVP - Chief Risk OfficerDec 19 '23Sale38.322469,42738,006Dec 20 04:33 PM
Young Mark RichardExec VPDec 19 '23Sale38.321847,05112,685Dec 20 04:36 PM
LAURSEN THOMAS EExecutive VP &Dec 19 '23Sale38.321766,74430,097Dec 20 04:34 PM
ALEXANDER BRUCE KExec VP andDec 19 '23Sale38.321164,44517,674Dec 20 04:34 PM
Stewart Randy RExec VPDec 19 '23Sale38.32883,37210,271Dec 20 04:35 PM
Forney Alan MExec VP & Division CEODec 19 '23Sale38.32823,14220,130Dec 20 04:35 PM
Huang Claire ADirectorMay 04 '23Buy20.0218,000360,37818,000May 08 06:07 PM
Robinson Rebecca KExecutive Vice PresidentMay 04 '23Buy20.3810,000203,78010,360May 05 04:58 PM
Huang Claire ADirectorMay 04 '23Buy19.986,000119,9046,000May 08 06:07 PM
Richards Robert RyanControllerMay 03 '23Option Exercise0.002,351011,058May 04 04:45 PM
SIMMONS HARRIS HChairman & CEOMay 03 '23Buy24.1620,000483,2001,274,990May 03 04:24 PM
Burdiss Paul E.Executive Vice PresidentMay 01 '23Buy27.4220,000548,43514,500May 03 04:27 PM
MCLEAN SCOTT JPresidentApr 28 '23Buy27.4437,0001,015,280104,540May 02 04:39 PM
Last Close
Mar 28 04:00PM ET
75.75
Dollar change
+0.29
Percentage change
0.38
%
MMSI Merit Medical Systems, Inc. daily Stock Chart
IndexRUT P/E46.82 EPS (ttm)1.62 Insider Own2.51% Shs Outstand57.86M Perf Week3.67%
Market Cap4.39B Forward P/E20.81 EPS next Y3.64 Insider Trans-4.63% Shs Float56.47M Perf Month-5.47%
Income94.41M PEG4.32 EPS next Q0.72 Inst Own100.34% Short Float4.00% Perf Quarter-1.24%
Sales1.25B P/S3.50 EPS this Y10.13% Inst Trans1.99% Short Ratio4.17 Perf Half Y11.45%
Book/sh20.77 P/B3.65 EPS next Y9.79% ROA4.73% Short Interest2.26M Perf Year4.87%
Cash/sh10.17 P/C7.45 EPS next 5Y10.83% ROE8.05% 52W Range62.58 - 85.62 Perf YTD-0.28%
Dividend Est.- P/FCF39.58 EPS past 5Y15.74% ROI4.54% 52W High-11.53% Beta0.89
Dividend TTM- Quick Ratio3.95 Sales past 5Y7.42% Gross Margin41.78% 52W Low21.05% ATR (14)1.54
Dividend Ex-Date- Current Ratio5.45 EPS Y/Y TTM25.11% Oper. Margin9.84% RSI (14)54.61 Volatility1.64% 2.15%
Employees6950 Debt/Eq0.74 Sales Y/Y TTM9.23% Profit Margin7.53% Recom1.56 Target Price94.22
Option/ShortYes / Yes LT Debt/Eq0.73 EPS Q/Q-17.88% Payout0.00% Rel Volume0.58 Prev Close75.46
Sales Surprise1.20% EPS Surprise5.72% Sales Q/Q11.04% EarningsFeb 28 AMC Avg Volume541.70K Price75.75
SMA202.40% SMA50-1.89% SMA2002.89% Trades Volume313,869 Change0.38%
Date Action Analyst Rating Change Price Target Change
Feb-07-24Initiated BofA Securities Neutral $87
Dec-21-23Upgrade Canaccord Genuity Hold → Buy $100
Dec-20-22Downgrade Canaccord Genuity Buy → Hold $73 → $72
Jan-05-21Upgrade Needham Hold → Buy $65
Sep-28-20Upgrade Wells Fargo Underweight → Equal Weight $42
Feb-25-20Downgrade Barrington Research Outperform → Mkt Perform
Feb-03-20Upgrade Raymond James Mkt Perform → Outperform $43
Dec-12-19Downgrade Wells Fargo Market Perform → Underperform $26
Sep-24-19Initiated Oppenheimer Outperform
Sep-10-19Downgrade Raymond James Outperform → Mkt Perform
Mar-27-24 09:40AM
Mar-20-24 11:28AM
Mar-19-24 09:25AM
Mar-18-24 05:19PM
Mar-08-24 05:00PM
09:40AM Loading…
09:40AM
Mar-07-24 10:43AM
Mar-05-24 09:25AM
Mar-01-24 04:32AM
Feb-29-24 11:24AM
11:03AM
07:38AM
Feb-28-24 07:00PM
06:15PM
05:21PM
04:05PM Loading…
04:05PM
04:05PM
Feb-23-24 09:15AM
Feb-21-24 10:00AM
Feb-19-24 08:38AM
Feb-15-24 09:25AM
Jan-31-24 12:10PM
09:50AM
Jan-30-24 09:55AM
Jan-24-24 01:01PM
Jan-23-24 07:19AM
Jan-16-24 04:05PM
Jan-08-24 09:00AM
Jan-03-24 04:05PM
Dec-27-23 05:11AM
04:05PM Loading…
Dec-18-23 04:05PM
Dec-15-23 09:50AM
Dec-11-23 10:25AM
Dec-06-23 09:00AM
Dec-04-23 04:05PM
Nov-15-23 07:28AM
Nov-01-23 09:55AM
Oct-31-23 11:40AM
Oct-30-23 01:37AM
Oct-27-23 12:20PM
11:16AM
10:51AM
Oct-26-23 07:30PM
05:50PM
05:48PM
04:40PM
04:05PM
07:52AM
Oct-25-23 10:21AM
Oct-12-23 11:55AM
Oct-10-23 11:40AM
09:25AM
Oct-05-23 11:05AM
09:25AM
Sep-19-23 09:00AM
Sep-07-23 07:22AM
Sep-06-23 09:25AM
Aug-30-23 12:46PM
Aug-15-23 01:20PM
Aug-10-23 07:58AM
Aug-08-23 06:50AM
Aug-03-23 09:25AM
Jul-26-23 12:07PM
Jul-25-23 08:00PM
05:45PM
04:43PM
04:05PM
Jul-21-23 06:51AM
Jul-13-23 11:56AM
Jul-11-23 11:40AM
Jul-07-23 07:20AM
Jul-06-23 01:11PM
Jul-03-23 07:51AM
Jun-26-23 10:50AM
Jun-22-23 11:40AM
Jun-21-23 08:00PM
11:35AM
Jun-19-23 10:24AM
Jun-14-23 11:51AM
11:22AM
Jun-13-23 01:59PM
11:22AM
Jun-09-23 01:39PM
Jun-08-23 04:01PM
12:44PM
Jun-07-23 04:23PM
01:53PM
12:52PM
Jun-06-23 12:37PM
10:20AM
Jun-05-23 02:12PM
11:45AM
Jun-02-23 12:44PM
Jun-01-23 11:28AM
11:17AM
10:14AM
May-31-23 12:07PM
12:04PM
May-26-23 11:31AM
10:55AM
Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. It operates through the Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups. The Endoscopy segment integrates non-vascular stent technology with balloon dilators, inflation devices, guide wires, procedure kits, and other devices that are used by gastroenterologists, endoscopists, pulmonologists, and thoracic and general surgeons. The company was founded by Fred P. Lampropoulos, Darla Gill, Kent W. Stanger, and William Padilla in July 1987 and is headquartered in South Jordan, UT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Parra Raul Jr.CFO AND TREASURERMar 12 '24Sale73.956,480479,18212,007Mar 13 06:36 PM
Wright JosephCHIEF COMMERCIAL OFFICERMar 07 '24Option Exercise28.2025,000705,00067,223Mar 08 03:40 PM
Wright JosephCHIEF COMMERCIAL OFFICERMar 07 '24Sale75.6825,0001,891,92542,223Mar 08 03:40 PM
Peterson NeilCHIEF OPERATING OFFICERMar 06 '24Option Exercise44.807,500336,00014,819Mar 08 10:11 AM
Gunderson Thomas JamesDirectorMar 04 '24Option Exercise34.4025,000860,00037,414Mar 05 12:13 PM
Gunderson Thomas JamesDirectorMar 04 '24Sale76.0318,1571,380,51319,257Mar 05 12:13 PM
Evans Stephen C.DirectorMar 04 '24Sale76.351,00076,3487,226Mar 05 10:13 AM
Millner F. AnnDirectorJan 22 '24Option Exercise34.4020,000688,00049,960Jan 24 10:49 AM
Millner F. AnnDirectorJan 22 '24Sale80.0020,0001,600,00029,960Jan 24 10:49 AM
LAMPROPOULOS FRED PPRESIDENT AND CEOAug 25 '23Option Exercise28.20200,0005,640,0001,167,916Aug 29 06:08 PM
LAMPROPOULOS FRED PPRESIDENT AND CEOAug 25 '23Option Exercise28.206,000169,20012,888Aug 29 06:08 PM
Peterson NeilCHIEF OPERATING OFFICERAug 22 '23Option Exercise28.208,000225,6008,000Aug 23 11:32 AM
Peterson NeilCHIEF OPERATING OFFICERAug 22 '23Sale67.918,000543,2880Aug 23 11:32 AM
ANDERSON A SCOTTDirectorAug 09 '23Option Exercise50.5025,0001,262,50071,397Aug 11 05:30 PM
ANDERSON A SCOTTDirectorAug 09 '23Sale69.4022,1801,539,29249,217Aug 11 05:30 PM